The present invention relates to a composition for preventing or treating hypertension, the composition comprising, as an active ingredient, a complex extract of Puerariae Radix, Platycodonis Radix, Liriopis Tuber, Dioscoreae Rhizoma, Coicis Semen, and Schisandrae Fructus. A pharmaceutical composition or food composition according to the present invention can be used to effectively prevent, ameliorate, or treat hypertension or hypertension-related diseases.

The present invention relates to a composition for preventing or treating hypertension, the composition comprising, as an active ingredient, a complex extract of Puerariae Radix, Platycodonis Radix, Liriopis Tuber, Dioscoreae Rhizoma, Coicis Semen, and Schisandrae Fructus. A pharmaceutical composition or food composition according to the present invention can be used to effectively prevent, ameliorate, or treat hypertension or hypertension-related diseases.

The present invention relates to a composition for preventing or treating hypertension, the composition comprising, as an active ingredient, a complex extract of Puerariae Radix, Platycodonis Radix, Liriopis Tuber, Dioscoreae Rhizoma, Coicis Semen, and Schisandrae Fructus. A pharmaceutical composition or food composition according to the present invention can be used to effectively prevent, ameliorate, or treat hypertension or hypertension-related diseases.

Therapeutic compositions for addressing physiological stresses and aging include an immune modulator and one or more adaptogenic nutrients. Some non-limiting examples of immune modulators include as transfer factor, low molecular weight fraction immune modulators and/or other low molecular weight fractions of colostrum, egg or any other source of transfer factor or low molecular weight fraction immune modulators. Methods for administering immune modulators and adaptogenic nutrients to a subject to address the effects of physiological stresses and aging in the body of the subject, such as inflammatory responses, are also disclosed.

Therapeutic compositions for addressing physiological stresses and aging include an immune modulator and one or more adaptogenic nutrients. Some non-limiting examples of immune modulators include as transfer factor, low molecular weight fraction immune modulators and/or other low molecular weight fractions of colostrum, egg or any other source of transfer factor or low molecular weight fraction immune modulators. Methods for administering immune modulators and adaptogenic nutrients to a subject to address the effects of physiological stresses and aging in the body of the subject, such as inflammatory responses, are also disclosed.

Therapeutic compositions for addressing physiological stresses and aging include an immune modulator and one or more adaptogenic nutrients. Some non-limiting examples of immune modulators include as transfer factor, low molecular weight fraction immune modulators and/or other low molecular weight fractions of colostrum, egg or any other source of transfer factor or low molecular weight fraction immune modulators. Methods for administering immune modulators and adaptogenic nutrients to a subject to address the effects of physiological stresses and aging in the body of the subject, such as inflammatory responses, are also disclosed.

Provided herein are compositions and methods of reducing certain psychoactive and physiological effects of tetrahydrocannabinol (THC), some of which may be undesirable, while preserving beneficial effects of cannabis in a human in need thereof. The methods described involve administration of therapeutically effective amounts of guineensine. Also, provided are compositions wherein guineensine is part of an herbal composition and is formulated for sublingual delivery.

Provided herein are compositions and methods of reducing certain psychoactive and physiological effects of tetrahydrocannabinol (THC), some of which may be undesirable, while preserving beneficial effects of cannabis in a human in need thereof. The methods described involve administration of therapeutically effective amounts of guineensine. Also, provided are compositions wherein guineensine is part of an herbal composition and is formulated for sublingual delivery.

Provided herein are compositions and methods of reducing certain psychoactive and physiological effects of tetrahydrocannabinol (THC), some of which may be undesirable, while preserving beneficial effects of cannabis in a human in need thereof. The methods described involve administration of therapeutically effective amounts of guineensine. Also, provided are compositions wherein guineensine is part of an herbal composition and is formulated for sublingual delivery.

Compositions and pharmaceutical forms for the treatment and prevention of coronavirus, which contain in its formulation non-hydrolyzed collagen as a surfactant with degreasing properties and natural active ingredients in the form of hydrolyzed powders of aqueous extracts of Dandelion (Taraxacum officinale), Anamu (Petiveria Alliacea), Epazote (Dysphania ambrosioides), oregano (Origanum vulgare), star anise (Lllicium verun) together with preservatives, as well as the obtaining and preparation procedures associated with the development of the different compositions and pharmaceutical forms.